USD 360.43
(-3.56%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 943.51 Million USD | 5.28% |
2022 | 840.58 Million USD | 4.75% |
2021 | 802.46 Million USD | 13.82% |
2020 | 705.06 Million USD | 2.56% |
2019 | 687.43 Million USD | -0.08% |
2018 | 688.01 Million USD | 0.58% |
2017 | 684.03 Million USD | 5.54% |
2016 | 648.1 Million USD | 3.79% |
2015 | 624.41 Million USD | -1.05% |
2014 | 631.06 Million USD | 4.58% |
2013 | 603.41 Million USD | 2.78% |
2012 | 587.1 Million USD | -0.84% |
2011 | 592.09 Million USD | 9.62% |
2010 | 540.13 Million USD | 6.07% |
2009 | 509.21 Million USD | -2.84% |
2008 | 524.1 Million USD | 6.3% |
2007 | 493.04 Million USD | 11.95% |
2006 | 440.4 Million USD | 11.01% |
2005 | 396.72 Million USD | 8.71% |
2004 | 364.92 Million USD | 7.25% |
2003 | 340.26 Million USD | 8.82% |
2002 | 312.68 Million USD | -21.52% |
2001 | 398.44 Million USD | 25.16% |
2000 | 318.34 Million USD | 8.91% |
1999 | 292.3 Million USD | 8.66% |
1998 | 269 Million USD | -0.07% |
1997 | 269.2 Million USD | 43.8% |
1996 | 187.2 Million USD | 12.16% |
1995 | 166.9 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 219.13 Million USD | -1.76% |
2024 Q2 | 216.42 Million USD | -1.23% |
2024 Q3 | 217.43 Million USD | 0.46% |
2023 FY | 884.95 Million USD | 5.28% |
2023 Q4 | 223.05 Million USD | -7.39% |
2023 Q1 | 226.12 Million USD | 0.93% |
2023 Q2 | 239.64 Million USD | 5.98% |
2023 Q3 | 240.85 Million USD | 0.51% |
2022 Q4 | 224.03 Million USD | 6.97% |
2022 FY | 840.58 Million USD | 4.75% |
2022 Q1 | 199.62 Million USD | -8.46% |
2022 Q2 | 207.48 Million USD | 3.94% |
2022 Q3 | 209.44 Million USD | 0.95% |
2021 Q2 | 204.97 Million USD | 11.93% |
2021 Q3 | 196.29 Million USD | -4.24% |
2021 Q4 | 218.08 Million USD | 11.1% |
2021 FY | 802.46 Million USD | 13.82% |
2021 Q1 | 183.12 Million USD | -6.3% |
2020 Q1 | 185.34 Million USD | 2.51% |
2020 FY | 705.06 Million USD | 2.56% |
2020 Q4 | 195.43 Million USD | 12.93% |
2020 Q3 | 173.05 Million USD | 14.44% |
2020 Q2 | 151.22 Million USD | -18.41% |
2019 Q3 | 162.98 Million USD | -5.22% |
2019 FY | 687.43 Million USD | -0.08% |
2019 Q1 | 171.68 Million USD | -6.34% |
2019 Q2 | 171.96 Million USD | 0.16% |
2019 Q4 | 180.8 Million USD | 10.93% |
2018 Q3 | 164.28 Million USD | -5.52% |
2018 Q1 | 166.54 Million USD | -10.24% |
2018 Q2 | 173.89 Million USD | 4.41% |
2018 FY | 688.01 Million USD | 0.58% |
2018 Q4 | 183.29 Million USD | 11.57% |
2017 Q4 | 185.55 Million USD | 8.73% |
2017 Q3 | 170.65 Million USD | 3.54% |
2017 Q2 | 164.82 Million USD | 1.11% |
2017 Q1 | 163 Million USD | -1.42% |
2017 FY | 684.03 Million USD | 5.54% |
2016 Q1 | 161.43 Million USD | 1.15% |
2016 Q2 | 164.57 Million USD | 1.94% |
2016 Q3 | 156.75 Million USD | -4.75% |
2016 FY | 648.1 Million USD | 3.79% |
2016 Q4 | 165.34 Million USD | 5.48% |
2015 Q2 | 155.71 Million USD | 3.0% |
2015 Q4 | 159.59 Million USD | 1.05% |
2015 Q3 | 157.93 Million USD | 1.42% |
2015 FY | 624.41 Million USD | -1.05% |
2015 Q1 | 151.17 Million USD | -7.4% |
2014 Q3 | 152.23 Million USD | -5.77% |
2014 Q4 | 163.25 Million USD | 7.24% |
2014 Q1 | 154.02 Million USD | -3.9% |
2014 Q2 | 161.55 Million USD | 4.89% |
2014 FY | 631.06 Million USD | 4.58% |
2013 Q3 | 146.68 Million USD | -2.27% |
2013 Q2 | 150.09 Million USD | 2.55% |
2013 FY | 603.41 Million USD | 2.78% |
2013 Q4 | 160.28 Million USD | 9.27% |
2013 Q1 | 146.36 Million USD | -2.14% |
2012 Q3 | 145.5 Million USD | -4.33% |
2012 FY | 587.1 Million USD | -0.84% |
2012 Q2 | 152.08 Million USD | 6.39% |
2012 Q1 | 142.95 Million USD | -6.14% |
2012 Q4 | 149.56 Million USD | 2.79% |
2011 FY | 592.09 Million USD | 9.62% |
2011 Q2 | 150.95 Million USD | 6.4% |
2011 Q3 | 146.95 Million USD | -2.65% |
2011 Q4 | 152.3 Million USD | 3.64% |
2011 Q1 | 141.87 Million USD | -2.92% |
2010 FY | 540.13 Million USD | 6.07% |
2010 Q1 | 129.41 Million USD | -2.27% |
2010 Q4 | 146.14 Million USD | 8.87% |
2010 Q3 | 134.23 Million USD | 2.99% |
2010 Q2 | 130.33 Million USD | 0.72% |
2009 Q2 | 131.98 Million USD | 9.89% |
2009 Q4 | 132.41 Million USD | 6.18% |
2009 FY | 509.21 Million USD | -2.84% |
2009 Q1 | 120.1 Million USD | -7.56% |
2009 Q3 | 124.7 Million USD | -5.52% |
2008 Q3 | 129.75 Million USD | -4.95% |
2008 Q1 | 127.89 Million USD | 2.24% |
2008 Q4 | 129.93 Million USD | 0.14% |
2008 Q2 | 136.51 Million USD | 6.74% |
2008 FY | 524.1 Million USD | 6.3% |
2007 Q3 | 129.72 Million USD | 5.07% |
2007 Q4 | 125.09 Million USD | -3.57% |
2007 Q2 | 123.47 Million USD | 7.6% |
2007 Q1 | 114.75 Million USD | -1.66% |
2007 FY | 493.04 Million USD | 11.95% |
2006 Q1 | 105.77 Million USD | 3.07% |
2006 Q4 | 116.69 Million USD | 8.11% |
2006 Q3 | 107.93 Million USD | -1.88% |
2006 Q2 | 110 Million USD | 4.0% |
2006 FY | 440.4 Million USD | 11.01% |
2005 Q2 | 100.61 Million USD | 2.02% |
2005 Q1 | 98.62 Million USD | -3.9% |
2005 FY | 396.72 Million USD | 8.71% |
2005 Q4 | 102.62 Million USD | 8.17% |
2005 Q3 | 94.86 Million USD | -5.71% |
2004 Q3 | 90.19 Million USD | 19.61% |
2004 Q2 | 75.4 Million USD | -22.02% |
2004 Q4 | 102.62 Million USD | 13.78% |
2004 Q1 | 96.69 Million USD | 6.25% |
2004 FY | 364.92 Million USD | 7.25% |
2003 Q1 | 82.73 Million USD | 96.76% |
2003 FY | 340.26 Million USD | 8.82% |
2003 Q4 | 91.01 Million USD | 9.62% |
2003 Q3 | 83.02 Million USD | -0.56% |
2003 Q2 | 83.49 Million USD | 0.93% |
2002 Q1 | 84.66 Million USD | -46.62% |
2002 FY | 312.68 Million USD | -21.52% |
2002 Q4 | 42.04 Million USD | -54.36% |
2002 Q3 | 92.11 Million USD | -1.59% |
2002 Q2 | 93.6 Million USD | 10.56% |
2001 Q3 | 80.46 Million USD | -0.27% |
2001 FY | 398.44 Million USD | 25.16% |
2001 Q1 | 86.56 Million USD | 3.8% |
2001 Q2 | 80.68 Million USD | -6.8% |
2001 Q4 | 158.61 Million USD | 97.13% |
2000 Q1 | 78.47 Million USD | -0.29% |
2000 Q4 | 83.39 Million USD | 6.56% |
2000 Q3 | 78.26 Million USD | 0.06% |
2000 Q2 | 78.21 Million USD | -0.33% |
2000 FY | 318.34 Million USD | 8.91% |
1999 Q1 | 70.2 Million USD | -1.96% |
1999 Q2 | 70.8 Million USD | 0.85% |
1999 Q3 | 72.6 Million USD | 2.54% |
1999 Q4 | 78.7 Million USD | 8.4% |
1999 FY | 292.3 Million USD | 8.66% |
1998 Q2 | 67.3 Million USD | 3.54% |
1998 Q3 | 65.2 Million USD | -3.12% |
1998 Q4 | 71.6 Million USD | 9.82% |
1998 FY | 269 Million USD | -0.07% |
1998 Q1 | 65 Million USD | 0.31% |
1997 FY | 269.2 Million USD | 43.8% |
1997 Q2 | 49.5 Million USD | -0.2% |
1997 Q3 | 105.3 Million USD | 112.73% |
1997 Q1 | 49.6 Million USD | -3.13% |
1997 Q4 | 64.8 Million USD | -38.46% |
1996 Q3 | 48.5 Million USD | 6.83% |
1996 Q1 | 42.1 Million USD | -9.07% |
1996 FY | 187.2 Million USD | 12.16% |
1996 Q4 | 51.2 Million USD | 5.57% |
1996 Q2 | 45.4 Million USD | 7.84% |
1995 Q2 | 40.1 Million USD | 2.3% |
1995 FY | 166.9 Million USD | 0.0% |
1995 Q1 | 39.2 Million USD | 0.0% |
1995 Q4 | 46.3 Million USD | 12.65% |
1995 Q3 | 41.1 Million USD | 2.49% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Agilent Technologies, Inc. | 2.11 Billion USD | 55.389% |
Charles River Laboratories International, Inc. | 885.29 Million USD | -6.577% |
Quest Diagnostics Incorporated | 1.61 Billion USD | 41.396% |
Danaher Corporation | 8.83 Billion USD | 89.317% |
Enzo Biochem, Inc. | 26.99 Million USD | -3394.896% |
IQVIA Holdings Inc. | 2.05 Billion USD | 54.042% |
Laboratory Corporation of America Holdings | 2.02 Billion USD | 53.324% |
Mettler-Toledo International Inc. | 1.08 Billion USD | 13.39% |
Qiagen N.V. | 777.67 Million USD | -21.325% |
Revvity, Inc. | 874.01 Million USD | -7.952% |
Thermo Fisher Scientific Inc. | 10.25 Billion USD | 90.799% |